Loading…

Loading grant details…

Completed HORIZON European Commission

Developing a surgical infection treatment to reduce amputations, healing times and hospital stays for diabetic foot patients


Funder European Commission
Recipient Organization Xtremedy Medical Limited
Country Ireland
Start Date Jul 01, 2022
End Date Dec 31, 2022
Duration 183 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 101069625
Grant Description

XTremedy Medical is a surgical ablation company founded in 2018 to commercialize technology treating deep wound infections, including Diabetic Foot Infections (DFI).

Our pulsed field ablation (PFA) system is the first to deliver electrical currents non-invasively to achieve superior clinical outcomes including faster cure of infections, reduced surgeries and shorter hospital stays.The Problem:Deep tissue and bone infections are life threatening infections that affect a millions of Europeans every year.

Immunosuppressed patients are particularly vulnerable, with Diabetic Foot Ulcer Infections a leading cause of amputations in Europe.

These patients are incredibly difficult to treat, requiring multiple surgeries, lengthy hospital stays and long-term antibiotics. In 20% of patients, an amputation is required to control the infection.

Surgical intervention to remove infected tissue is the cornerstone of treatment but surgeons must balance removing infected material whilst preserving healthy tissue required for healing.

Treatment Landscape:Current treatment modalities either only treat the surface of the wound or use mechanical forces to treat below the surface. Surface treatments fail as they leave infection below the wound bed untreated.

Mechanical devices can cause more severe infections by damaging the integrity of the wound bed and propelling the infection deeper.

As a result, these treatments are often ineffective, with 50% of patients requiring additional surgeries.XTremedy Solution:XTremedy Medical have developed a surgical device that delivers electrical signals through the wound. This device treats both the surface and below to zap any residual infection.

The technology is non-thermal and preserves the integrity of the wound during treatment, helping reduce the time required for healing. Patients benefit from reduced surgeries, shortened hospital stays and antibiotic durations following surgery.

All Grantees

Xtremedy Medical Limited

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant